1888PressRelease – The market for musculosketal drugs equates to about 14% of the pharma total and is growing at over 7% year on year. Many musculosketal disorders are incurable so that patients will take these pain- and inflammation-reducing drugs either continuously or periodically for life. As their incidence is age-related, the increase in the size of the aging population is one factor driving the growth.
The world market for drugs that treat diseases such as arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome and muscular dystrophy has been growing at more than 7% a year since 2012 and is predicted to go on growing at a slightly faster rate to 2020.
Many musculosketal disorders are incurable so that patients will take these pain- and inflammation-reducing drugs either continuously or periodically for life. As their incidence is age-related, the increase in the size of the aging population is one factor driving the growth of this market. Other factors are increasing global obesity and stress levels.
Globally, the market for musculosketal drugs equates to about 14% of the pharma total and is growing at over 7% year on year. This compares with growth rates around 5% for pharmaceuticals in general.
Growth has been and will continue to be spread across all regions of the world, though faster in some than others. The North American market, worth nearly a third of the total at $38 billion, is predicted to grow to nearly $52 billion by 2020 at a rate of 8% a year. However, the Asia Pacific market, though smaller than the North American at $26 billion in 2016, is expected to grow faster at 11% a year. Africa’s market will grow at the second fastest pace globally, although its share in 2020 will still be under 3% of the global figure.
The market is fragmented, with the top ten brands accounting for only about 11% of the total. Hoffman-Laroche, GlaxoSmithKline, Pfizer, Daiichi Sankyo and Abbott laboratories are among the largest players in this market.
Where to Learn More
Read Musculoskeletal Disorders Drugs Market Global Report 2017 from The Business Research Company for information on the following:
Markets Covered: Rheumatoid Arthritis, Muscle Relaxants, Others
Companies Mentioned: AbbVie, Amgen, Johnson & Johnson, F. Hoffmann-La Roche Ltd, and Pfizer Inc.
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Musculoskeletal Disorders Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Interested to know more? Here is a full scope of Biologics and Pharmaceutical Drugs Market reports to explore:
1. Pharmaceutical Drugs Market Global Report 2017
2. Anti-infective Drugs Market Global Report 2017
3. Cardiovascular Drugs Market Global Report 2017
4. Central Nervous System Drugs Market Global Report 2017
5. Dermatology Drugs Market Global Report 2017
6. Genito-urinary Drugs Market Global Report 2017
7. Hematology Drugs Market Global Report 2017
8. Metabolic Disorder Drugs Market Global Report 2017
9. Ophthalmology Drugs Market Global Report 2017
10. Gastrointestinal Drugs Market Global Report 2017
11. Respiratory Drugs Market Global Report 2017
12. Biologics Market Global Report 2017
13. Oncology Drugs Market Global Report 2017
About The Business Research Company
Visit TheBusinesResearchCompany.com. The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has research professionals at its office in the UK, India, and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. The Business Research Company’s management have more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world’s largest organizations. The Business Research Company’s Consultant have master’s qualifications from top institutes and include MBAs, MSCs, CFAs and CAs. The Business Research Company’s Consultants gain training and qualifications from the market Research Society and are trained in advanced research practices, techniques, and ethics.